RecruitingPHASE1NCT07239609

Acceptance and Commitment Therapy for Individuals With MNCD and Their Care Partners: An In-Person and Telehealth Individual Therapy Approach

Sponsor: Texas Tech University

Trial Details

Condition	Depression in Adults, Anxiety Disorder Generalized, Grief
Intervention	Acceptance Commitment Therapy
Phase	PHASE1
Status	Recruiting
Participants	100
Est. Completion	31 Oct 2027
Last Updated	15 May 2026

Primary Outcome

Patient Health Questionnaire-9; Geriatric Depression Short From; The Generalized Anxiety Disorder-7; General Anxiety Scale-10; Pre-death grief-12

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria Inclusion (person with MCI or MNCD): * 18+ * MMSE= 21-27 * Able to communicate in English Inclusion (care partner): * 18+ * Identifies as a care partner of a person with MNCD * Able to communicate in English * MMSE= 28-30 * Is a family member or friend of the person with MNCD Exclusion Criteria Exclusion (person with MCI or MNCD): * Currently in an intervention for reducing anxiety or depression related to their dementia * MMSE= 28+ or less than 21 Exclusion (care partner): * MMSE= \<28 * Is a formal (paid) caregiver

Trial Sites

Countries

United States

View Registry Entry

Related Analysis

Phase I Trial Opens: Acceptance and Commitment Therapy for Dementia Patients and Caregivers — What Clinicians Need to Know

New Phase I trial evaluates Acceptance and Commitment Therapy for dementia patients and their caregivers together. The dyadic approach addresses depression, anxiety, and grief in both parties simultaneously through in-person and telehealth delivery.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service